Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

Liping Zhuang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1998-8250; OpenAlex author ID A5060360779. Sources: OpenAlex.

Their work

Papers
11 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
37
Papers, trials and grants by year

2013: 2 papers · 2014: none · 2015: none · 2016: 3 papers · 2017: none · 2018: none · 2019: 2 papers · 2020: 2 papers · 2021: 1 paper · 2022: none · 2023: 1 paper

Papers 11

  1. Circulating tumor-associated autoantibodies as novel diagnostic biomarkers in pancreatic adenocarcinoma. Co-author DOI 10.1002/ijc.34334↗
  2. Combined ablation-chemotherapy versus chemotherapy alone for pancreatic cancer with liver metastasis: a propensity score matching study. Co-author DOI 10.1080/17474124.2021.1869937↗
  3. [Expression of miRNA let-7a and HMGA2 and Diagnostic Value of Serum miRNA let-7a Level in Pancreatic Cancer]. Co-author DOI 10.12182/20200760107↗
  4. miR-939-5p Contributes to the Migration and Invasion of Pancreatic Cancer by Targeting ARHGAP4. Co-author DOI 10.2147/ott.s227644↗
  5. High-intensity focused ultrasound enhances the effect of bufalin by inducing apoptosis in pancreatic cancer cells. Co-author DOI 10.2147/ott.s185953↗
  6. ARHGAP4 mediates the Warburg effect in pancreatic cancer through the mTOR and HIF-1α signaling pathways. Co-author DOI 10.2147/ott.s207560↗
  7. A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy. First author DOI 10.1002/cncr.30057↗
  8. A retrospective analysis of survival factors of high intensity focused ultrasound (HIFU) treatment for unresectable pancreatic cancer. Co-author PMID 27448780↗
  9. Radiation promotes epithelial-to-mesenchymal transition and invasion of pancreatic cancer cell by activating carcinoma-associated fibroblasts. Co-author PMID 27822411↗
  10. The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting… First author DOI 10.1016/j.molonc.2012.10.011↗
  11. MicroRNA 23b regulates autophagy associated with radioresistance of pancreatic cancer cells. Co-author DOI 10.1053/j.gastro.2013.07.048↗

Closest collaborators

The 25 strongest of 37 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhiqiang Meng · 8 shared papers, 2013–2023 · strength 0.72
  2. Zhouyu Ning · 5 shared papers, 2016–2023 · strength 0.53
  3. Yehua Shen · 4 shared papers, 2016–2021 · strength 0.43
  4. Peng Wang · 3 shared papers, 2013–2023 · strength 0.26
  5. Chien‐shan Cheng · 2 shared papers, 2016–2023 · strength 0.25
  6. Gang Chen · 2 shared papers, 2019–2020 · strength 0.24
  7. Yan Xia · 2 shared papers, 2019–2021 · strength 0.22
  8. Luming Liu · 3 shared papers, 2013–2019 · strength 0.20
  9. Changjing Huang · 1 shared paper, 2023 · strength 0.19
  10. Wen‐Bin Zou · 1 shared paper, 2023 · strength 0.19
  11. Luming Liu · 2 shared papers, 2013–2020 · strength 0.16
  12. Xing-Bo Mao · 1 shared paper, 2020 · strength 0.15
  13. Guo-Gang Zhao · 1 shared paper, 2020 · strength 0.15
  14. Yongqiang Hua · 1 shared paper, 2021 · strength 0.13
  15. Huifeng Gao · 1 shared paper, 2020 · strength 0.13
  16. Ye Li · 1 shared paper, 2020 · strength 0.13
  17. Zhen Chen · 3 shared papers, 2013–2016 · strength 0.12
  18. Chenyue Zhang · 1 shared paper, 2019 · strength 0.09
  19. Lianyu Chen · 2 shared papers, 2013–2016 · strength 0.09
  20. Juan Zhang · 2 shared papers, 2013 · strength 0.07
  21. Jie Fan · 2 shared papers, 2013 · strength 0.07
  22. Doudou Li · 1 shared paper, 2016 · strength 0.06
  23. Chao Qu · 1 shared paper, 2016 · strength 0.06
  24. Peng Wang · 1 shared paper, 2016 · strength 0.06
  25. Shulin Yu · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.